873302-37-5 Usage
Uses
Used in Pharmaceutical Industry:
3-(5-BROMO-PYRIDIN-3-YL)-PROP-2-YN-1-OL is used as an intermediate in the synthesis of pharmaceuticals for its ability to react with other chemicals to form new compounds with different properties. Its unique structure allows for the development of novel drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical industry, 3-(5-BROMO-PYRIDIN-3-YL)-PROP-2-YN-1-OL is used as an intermediate in the synthesis of agrochemicals, contributing to the development of new pesticides and other agricultural chemicals that can improve crop protection and yield.
Used in Material Science:
3-(5-BROMO-PYRIDIN-3-YL)-PROP-2-YN-1-OL is utilized in the development of new materials due to its potential to form compounds with unique properties. Its involvement in material science can lead to the creation of innovative materials with applications in various industries.
Used in Biological Research:
3-(5-BROMO-PYRIDIN-3-YL)-PROP-2-YN-1-OL is also used in biological research as a tool to study the interactions between different biomolecules and to develop new methods for understanding biological processes. Its bioactivity makes it a valuable component in the exploration of novel biological pathways and mechanisms.
Check Digit Verification of cas no
The CAS Registry Mumber 873302-37-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,3,3,0 and 2 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 873302-37:
(8*8)+(7*7)+(6*3)+(5*3)+(4*0)+(3*2)+(2*3)+(1*7)=165
165 % 10 = 5
So 873302-37-5 is a valid CAS Registry Number.
InChI:InChI=1/C8H6BrNO/c9-8-4-7(2-1-3-11)5-10-6-8/h4-6,11H,3H2
873302-37-5Relevant academic research and scientific papers
Pyrrolopyrimidines and Pyrrolopyridines
-
Page/Page column 55, (2009/07/25)
Compounds of formula I in free or salt or solvate form, wherein X, T1, T3 and T4 have the meanings as indicated in the specification, are useful for treating diseases mediated by the ALK-5 and/or ALK-4 receptor. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
